Table 3.
Proportion of Derivation and Validation Cohorts Who Did Not Complete7-Vaccine Series by Age 19 Months by Risk Category
| Risk Categorya | Derivation Cohort (N = 6053) | Validation Cohort (N = 3027) | ||
|---|---|---|---|---|
| n | % | n | % | |
| Low | 1371/3543 | 38.7 | 664/1792 | 37.1 |
| Medium | 1027/1948 | 52.7 | 504/955 | 52.8 |
| High | 433/562 | 77.1 | 214/280 | 76.4 |
aLow (0-2 risk score), medium (3-4 risk score), and high (5-7 risk score).